Metastatic castration-resistant prostate cancer (mCRPC) treatment can involves chemotherapy, radiation, and more. Find the ...

The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.

In 2019, Michael Rosenblum received an experimental new prostate cancer treatment after the disease spread to his bones. He remains symptom-free. The treatment is now approved for more patients. The ...

Bayer will present new data from the ARANOTE trial evaluating ultra-low prostate-specific antigen responses with NUBEQA ® ...

In many cases, however, these advanced therapies ultimately fail, highlighting the need for new approaches to restore sensitivity in castrate-resistant prostate cancer and improve treatment outcomes.